BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences Corporation, a Roche company, announced the launch of the new GS FLX Titanium series reagents and software that are transforming the life science’s industry. The new reagent kits provide individual sequencing reads with an improved Q20 length of 400 base pairs (99% accuracy at the 400th base and higher for preceding bases) and a five-fold increase in throughput to 400 – 600 million base pairs per instrument run. The new level of performance solidifies the position of 454 Life Science as the new gold standard in sequencing, effectively replacing traditional Sanger sequencing for most applications.
